---
title: "TIANYU PHARM: Montelukast Sodium Tablets have obtained the drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244456616.md"
description: "TIANYU PHARM's wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical, recently obtained the drug registration certificate for Montelukast Sodium Tablets issued by the National Medical Products Administration. This medication is suitable for the prevention and long-term treatment of asthma in adults aged 15 and older, including alleviating symptoms of allergic rhinitis"
datetime: "2025-06-13T12:48:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244456616.md)
  - [en](https://longbridge.com/en/news/244456616.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244456616.md)
generator: "portal-rs"
---

# TIANYU PHARM: Montelukast Sodium Tablets have obtained the drug registration certificate

According to the Zhitong Finance APP, TIANYU PHARM (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" for Montelukast Sodium Tablets approved and issued by the National Medical Products Administration (referred to as "NMPA").

Montelukast Sodium Tablets are indicated for the prevention and long-term treatment of asthma in adults aged 15 years and older, including the prevention of daytime and nighttime asthma symptoms, treatment of asthma patients sensitive to aspirin, and prevention of exercise-induced bronchoconstriction; this product is suitable for alleviating symptoms caused by allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis in adults aged 15 years and older)

### Related Stocks

- [300702.CN](https://longbridge.com/en/quote/300702.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [SpaceX has some of the world's biggest investors on board. Meet 10 of its top shareholders.](https://longbridge.com/en/news/296512739.md)
- [FOCUS-As Europe rearms, Italy's fragmented space sector faces a scale test](https://longbridge.com/en/news/296303505.md)
- [Elon Musk gives a timeline for SpaceX’s first Starship catch attempt](https://longbridge.com/en/news/296516633.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**